Financial statements Advachemlab
Balance sheet data of ADVACHEMLAB
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 2 642 613,83 | 2 575 668,38 | 2 588 408,88 | 2 587 632,15 | 2 271 099,47 | 2 522 979,68 |
A. Fixed assets | 2 039 741,96 | 2 047 241,96 | 2 031 345,18 | 2 031 345,18 | 2 031 345,18 | 2 031 345,18 |
B. Current assets | 602 871,87 | 528 426,42 | 557 063,70 | 556 286,97 | 239 754,29 | 491 634,50 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 2 642 613,83 | 2 575 668,38 | 2 588 408,88 | 2 587 632,15 | 2 271 099,47 | 2 522 979,68 |
A. Equity | 2 626 266,27 | 2 562 525,62 | 2 575 336,26 | 2 570 457,01 | 2 262 174,59 | 2 495 421,68 |
B. Liabilities and provisions for liabilities | 16 347,56 | 13 142,76 | 13 072,62 | 17 175,14 | 8 924,88 | 27 558,00 |
I. Long-term liabilities | - | - | - | - | - | - |
II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.